A compound probiotic preparation for improving immunity and resisting HPV infection

The composite coagulation method of whey protein isolate and gum arabic isolate to embed probiotics and Chinese herbal medicines to form a compound probiotic preparation, solving the problem of low survival rate of probiotics and achieving the effect of improving immunity and resisting HPV infection.

CN118383521BActive Publication Date: 2024-11-22ZHONGKE RUIPIEN HEBEI BIOTECHNOLOGY CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202311340332.X
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-10-17
Publication Date
2024-11-22
Estimated Expiration
2043-10-17

AI Technical Summary

Technical Problem

The viability of existing probiotics during processing and storage and survival rate in the human gastrointestinal tract is relatively low, making it difficult to effectively improve immunity and resist HPV infection.

Method used

Use whey protein isolate and gum arabic as the wall material of microcapsules, and embed a variety of active probiotics and Chinese herbal medicines through the composite coagulation method to form a compound probiotic preparation, improve the survival rate of probiotics in the human digestive tract and ensure the smoothness of Chinese medicine ingredients. release.

Benefits of technology

It significantly improves the survival rate of probiotics in the human intestines and the release efficiency of traditional Chinese medicine ingredients, enhances the body's immunity, has powerful anti-inflammatory, bactericidal and anti-HPV infection effects, and is simple in process and suitable for mass production.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118383521B_ABST
    Figure CN118383521B_ABST
Patent Text Reader

Abstract

The present invention discloses a compound probiotic preparation for improving immunity and resisting HPV infection. The preparation uses whey protein isolate, gum arabic and gelatin as wall materials, and uses a composite coacervation method to embed a variety of active probiotics and Chinese herbal medicines, greatly improving the survival rate of probiotics in the human digestive tract, and ensuring the smooth release of probiotics and Chinese herbal medicine components in the intestine. At the same time, the probiotic preparation of the present invention, on the basis of regulating the balance of human intestinal flora, adds Chinese herbal medicines such as astragalus, tangerine peel, and codonopsis, which can greatly enhance human immunity, thereby producing the effects of anti-inflammatory, sterilization, and resisting HPV infection.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of probiotics and relates to a compound probiotic preparation for improving immunity and resisting HPV infection. Background Art

[0002] Over the past two decades, consumers have placed increasing emphasis on consuming healthier foods and foods with higher nutritional value. In light of this new reality, the functional food industry has gained prominence, representing one of the most dynamic and innovative categories in the food industry, an important component of which is probiotics. However, there are many challenges in this food industry sector, such as the viability of these microorganisms during processing and product storage, as well as their low survival rate in the human gastrointestinal tract. To overcome these limitations, existing solutions include adequate selection of bacterial strains, adaptation to stress, incorporation of micronutrients, and microencapsulation.

[0003] Currently, complex coacervation is one of the most widely used microencapsulation methods. The process is based on the attractive interaction between two biopolymers with opposite charges at a given pH, which leads to phase separation in the system, thereby leading to the formation of coacervation complexes. Among the biopolymers commonly used in the complex coacervation process, the present invention selects two substances, gum arabic and gelatin. Gum arabic is an arabinogalactan polysaccharide-protein anion complex composed of three different components; gelatin, as a biodegradable protein material, is still the main commercial choice as a microcapsule wall material due to its excellent water solubility, emulsification and thickening ability and high cross-linking activity. Summary of the invention

[0004] The present invention relates to a compound probiotic preparation for improving immunity and resisting HPV infection, and the present invention is achieved through the following technical scheme:

[0005] S1. Pretreatment of probiotic microcapsule wall material: weigh 30-120g of food-grade gum arabic and 30-120g of gelatin powder, add them to 1-4L of distilled water under sterile conditions, stir for 3h at room temperature to make them completely hydrated, and then store them at 25°C for 12h for standby use; weigh 60-240g of whey protein isolate purchased from Hilma Co., Ltd. of the United States and 2L of sterile distilled water, stir for 30min at room temperature, then transfer the solution to a water bath at 80°C, heat and stir for 30min, and then cool to 25°C for standby use;

[0006] S2, coagulation of probiotic microcapsule wall material: weigh 50-200 mL of the gum arabic and gelatin solution prepared in S1 and 100-400 mL of the whey protein isolate solution, stir them together for 10 min, then slowly add 10% by weight lactic acid solution to adjust the pH to 1.0, let stand aseptically at room temperature of 20° C. for 2 h to separate the phases, then filter the solution to obtain the precipitate, i.e., the probiotic microcapsule wall material;

[0007] S3, preparation of compound probiotic dispersion: weigh 10-20g of commercially purchased Bifidobacterium breve BB-G95, 10-20g of Bifidobacterium animalis Bb-12, 10-20g of Bifidobacterium lactis Bi-07, 10-20g of Bifidobacterium bifidum, 10-20g of Lactobacillus casei, 5-10g of Lactobacillus plantarum, 5-10g of Lactobacillus reuteri, 5-10g of Lactobacillus delbrueckii subsp. lactis bulgaricus, 5-10g of Pediococcus acidilactici, 2-4g of Astragalus powder, 1-2g of dried tangerine peel powder, 1-2g of Codonopsis pilosula powder, and 10-30mL of polyglycerol polyricinoleate, place in 1-2L of corn oil, stir for 2h at 20°C to mix evenly, let stand for 12h to take out the precipitate for later use;

[0008] S4. Compound probiotic microcapsule molding: Weigh 100-200 g of the probiotic microcapsule wall material prepared in S2 and 100-200 g of the probiotic mixed precipitate prepared in S3, add them into a Wilmington homogenizer from the United States and stir at 5000 r / min for 90 seconds, then take out the microcapsule, dehydrate the solid material by freeze-drying and package it, and thus obtain a compound probiotic preparation that can enhance human immunity and resist HPV infection.

[0009] Note: All the probiotics required in this experiment were purchased from Shanghai Yaorunying Biotechnology Co., Ltd.

[0010] Preferably: the food-grade gum arabic, gelatin and whey protein isolate weighed in S1 are 30 g, 30 g and 60 g, respectively;

[0011] Preferably: S2 weighs 50 mL of the gum arabic and gelatin solution prepared in S1 and 100 mL of the whey protein isolate solution;

[0012] Preferably: the S3 weighs 10 g of Bifidobacterium breve BB-G95, 10 g of Bifidobacterium animalis Bb-12, 10 g of Bifidobacterium lactis Bi-07, 10 g of Bifidobacterium bifidum, 10 g of Lactobacillus casei, 5 g of Lactobacillus plantarum, 5 g of Lactobacillus reuteri, 5 g of Lactobacillus delbrueckii subsp. lactis bulgaricus, 5 g of Pediococcus acidilactici, 2 g of Astragalus powder, 1 g of Tangerine peel powder, 1 g of Codonopsis pilosula powder, 10 mL of polyglycerol polyricinoleate, and 1 L of corn oil;

[0013] Preferably: 100 mL of the co-cultured erythromycin prepared by S3 and 20 mL of sterile water are weighed and mixed evenly in S4, and 150 mL of commercial lactobionic acid with a purity of 97% is used;

[0014] Preferably, the probiotic microcapsule wall material prepared by S2 weighed in S4 is 100 g, and the probiotic mixed precipitate prepared by S3 is 100 g.

[0015] The invention is beneficial in that:

[0016] 1. The present invention discloses a compound probiotic preparation for improving immunity and resisting HPV infection. The preparation uses whey protein isolate and gum arabic as wall materials, and uses a composite coacervation method to embed a variety of active probiotics and Chinese herbal medicines, thereby greatly improving the survival rate of probiotics in the human digestive tract and ensuring the smooth release of probiotics and Chinese herbal medicine components in the intestine.

[0017] 2. The probiotic preparation of the present invention not only regulates the balance of human intestinal flora, but also adds Chinese herbal medicines such as astragalus, tangerine peel, and codonopsis. These formulas have synergistic functions, which can greatly enhance human immunity, thereby producing the effects of anti-inflammatory, bactericidal, and resistance to HPV infection.

[0018] 3. The compound probiotic preparation prepared by the present invention has a simple process, is suitable for batch production, and has extremely high medicinal value. BRIEF DESCRIPTION OF THE DRAWINGS

[0019] Figure 1 This is a microscopic photograph of the water droplet-shaped microcapsule of Example 1.

[0020] Figure 2 The mechanical strength data of the microcapsules of Example 1 and Comparative Examples 1-5 of the present invention are shown in FIG.

[0021] Figure 3 This is a graph showing the survival rate of the compound probiotics in the in vitro simulated fluid of Examples 1-3 of the present invention and Comparative Examples 1-10.

[0022] Figure 4 It is a data diagram of humoral immune function of Example 4 of the present invention and Comparative Examples 11-13.

[0023] Figure 5 It is a graph showing the NK cell activity data of Example 4 of the present invention and Comparative Examples 11-13. DETAILED DESCRIPTION

[0024] The following describes the embodiments of the present invention by specific examples, and those skilled in the art can easily understand other advantages and effects of the present invention from the contents disclosed in this specification. The present invention can also be implemented or applied through other different specific embodiments, and the details in this specification can also be modified or changed in various ways based on different viewpoints and applications without departing from the spirit of the present invention. It should be noted that the following embodiments and features in the embodiments can be combined with each other without conflict.

[0025] Example 1

[0026] S1. Pretreatment of probiotic microcapsule wall material: Weigh 30 g of food-grade gum arabic and 30 g of gelatin powder, add them to 1 L of distilled water under sterile conditions, stir for 3 h at room temperature to fully hydrate them, and then store them at 25 ° C for 12 h for standby use; weigh 60 g of whey protein isolate purchased from Hilma Co., Ltd., USA, and 2 L of sterile distilled water, stir for 30 min at room temperature, then transfer the solution to a water bath at 80 ° C, heat and stir for 30 min, and then cool to 25 ° C for standby use;

[0027] S2. Agglomeration of probiotic microcapsule wall material: 50 mL of the gum arabic and gelatin solution prepared in S1 and 100 mL of the whey protein isolate solution were weighed and stirred for 10 min, then a 10% by weight lactic acid solution was slowly added to adjust the pH to 1.0, and the mixture was allowed to stand aseptically at room temperature of 20° C. for 2 h to allow phase separation, and then the solution was filtered to obtain the precipitate, i.e., the probiotic microcapsule wall material;

[0028] S3. Preparation of compound probiotic dispersion: Weigh 10 g of commercially purchased Bifidobacterium breve BB-G95, 10 g of Bifidobacterium animalis Bb-12, 10 g of Bifidobacterium lactis Bi-07, 10 g of Bifidobacterium bifidum, 10 g of Lactobacillus casei, 5 g of Lactobacillus plantarum, 5 g of Lactobacillus reuteri, 5 g of Lactobacillus delbrueckii subsp. lactis bulgaricus, 5 g of Pediococcus acidilactici, 2 g of Astragalus powder, 1 g of Tangerine peel powder, 1 g of Codonopsis pilosula powder, and 10 mL of polyglycerol polyricinoleate, place in 1 L of corn oil, stir for 2 h at 20 ° C to mix evenly, let stand for 12 h to take out the precipitate for later use;

[0029] S4. Compound probiotic microcapsule molding: Weigh 100 g of the probiotic microcapsule wall material prepared in S2 and 100 g of the probiotic mixed precipitate prepared in S3, add them into a Wilmington homogenizer from the United States and stir at 5000 r / min for 90 s, then take out the microcapsules, dehydrate the solid materials by freeze-drying and package them, and thus obtain a compound probiotic preparation that can enhance human immunity and resist HPV infection.

[0030] Comparative Example 1: In step S1, 60 g of food-grade gum arabic and 6 g of gelatin were weighed and the ratio was adjusted to 10:1. Other parameters were the same as those in Example 1.

[0031] Comparative Example 2: In step S1, 60 g of food-grade gum arabic and 12 g of gelatin were weighed and the ratio was adjusted to 5:1. Other parameters were the same as those in Example 1.

[0032] Comparative Example 3: In step S1, 60 g of food-grade gum arabic and 30 g of gelatin were weighed and the ratio was adjusted to 2:1. Other parameters were the same as those in Example 1.

[0033] Comparative Example 4: In step S1, 30 g of food-grade gum arabic and 60 g of gelatin were weighed and the ratio was adjusted to 1:2. Other parameters were the same as those in Example 1.

[0034] Comparative Example 5: In step S1, 30 g of food-grade gum arabic and 120 g of gelatin were weighed and the ratio was adjusted to 1:4. Other parameters were the same as those in Example 1.

[0035] The mechanical strength of Example 1 and Comparative Examples 1-4 was tested by a pump circulation method and compared, and the breakage rate was used to characterize the mechanical strength.

[0036] Damage rate (%) = [1-(mass of undamaged microcapsules after cycling / total mass of microcapsules before cycling)] × 100%. Each sample was tested 5 times in parallel. The results are shown in Table 1.

[0037] Table 1 Microcapsule mechanical strength data

[0038]

[0039] After experimental comparison, we can draw the following conclusion: the microcapsule wall material composed of the composite combination of gum arabic and gelatin with a mass ratio of 1:1 has higher mechanical strength than the capsule wall material prepared with other ratios. Figure 1 The microscopic photographs clearly show the structure of the compound probiotics and Chinese medicine powder encapsulated in the water drop-shaped microcapsules of Example 1. By observing the breakage rates of Example 1 and Comparative Examples 1-3, it can be seen that when the difference between the proportions of gum arabic and gelatin in the microcapsule wall material is as large as 10:1, the mechanical strength of the microcapsule wall material is greatly lost, and the breakage rate is almost three times that of the example. When the difference between the two proportions is narrowed to 2:1, the breakage rate shows a downward trend. When the ratio of the two is 1:1, the mechanical strength is the highest and the microcapsule breakage is the least. When the proportion of gum arabic and gelatin in the microcapsule wall material continues to expand in the opposite direction to 1:4, the breakage rate of the microcapsule shows an increasing trend. This shows that when the mass ratio of gum arabic and gelatin is 1:1, the mechanical strength of the microcapsule wall material is the highest, and the synergistic effect of the two reaches the strongest contribution to the integrity of the microcapsule.

[0040] Example 2

[0041] S1. Pretreatment of probiotic microcapsule wall material: Weigh 60 g of food-grade gum arabic and 60 g of gelatin powder, add them to 2 L of distilled water under sterile conditions, stir for 3 h at room temperature to fully hydrate them, and then store them at 25 ° C for 12 h for standby use; weigh 120 g of whey protein isolate purchased from Hilma Co., Ltd., USA, and 2 L of sterile distilled water, stir for 30 min at room temperature, and then transfer the solution to a water bath at 80 ° C, heat and stir for 30 min, and then cool to 25 ° C for standby use;

[0042] S2, coagulation of probiotic microcapsule wall material: weigh 100 mL of the gum arabic and gelatin solution prepared in S1 and 200 mL of the whey protein isolate solution, stir them together for 10 min, then slowly add 10% by weight lactic acid solution to adjust the pH to 1.0, let stand aseptically at room temperature of 20° C. for 2 h to separate the phases, then filter the solution to obtain the precipitate, i.e., the probiotic microcapsule wall material;

[0043] S3, preparation of compound probiotic dispersion: weigh 15g of commercially purchased Bifidobacterium breve BB-G95, 15g of Bifidobacterium animalis Bb-12, 15g of Bifidobacterium lactis Bi-07, 15g of Bifidobacterium bifidum, 15g of Lactobacillus casei, 7g of Lactobacillus plantarum, 7g of Lactobacillus reuteri, 7g of Lactobacillus delbrueckii subsp. lactis bulgaricus, 7g of Pediococcus acidilactici, 3g of Astragalus powder, 1.5g of dried tangerine peel powder, 1.5g of Codonopsis pilosula powder, and 20mL of polyglycerol polyricinoleate, put them in 1.5L of corn oil, stir for 2h at 20°C to mix evenly, let stand for 12h to take out the precipitate for later use;

[0044] S4. Compound probiotic microcapsule molding: Weigh 150 g of the probiotic microcapsule wall material prepared in S2 and 150 g of the probiotic mixed precipitate prepared in S3, add them into a Wilmington homogenizer from the United States and stir at 5000 r / min for 90 s, then take out the microcapsules, dehydrate the solid materials by freeze-drying and package them, and thus obtain a compound probiotic preparation that can enhance human immunity and resist HPV infection.

[0045] Comparative Example 6: In step S1, 60 g of food-grade gum arabic and 30 g of whey protein isolate were weighed and the ratio was adjusted to 2:1. Other parameters were the same as those in Example 2.

[0046] Comparative Example 7: In step S1, 60 g of food-grade gum arabic and 60 g of whey protein isolate were weighed and the ratio was adjusted to 1:1. Other parameters were the same as those in Example 2.

[0047] Comparative Example 8: In step S1, 60 g of food-grade gum arabic and 180 g of whey protein isolate were weighed and the ratio was adjusted to 1:3. Other parameters were the same as those in Example 2.

[0048] Example 3

[0049] S1. Pretreatment of probiotic microcapsule wall material: Weigh 90 g of food-grade gum arabic and 90 g of gelatin powder, add them to 3 L of distilled water under sterile conditions, stir for 3 h at room temperature to fully hydrate them, and then store them at 25 ° C for 12 h for standby use; weigh 180 g of whey protein isolate purchased from Hilma Co., Ltd., USA, and 2 L of sterile distilled water, stir for 30 min at room temperature, and then transfer the solution to a water bath at 80 ° C, heat and stir for 30 min, and then cool to 25 ° C for standby use;

[0050] S2. Agglomeration of probiotic microcapsule wall material: 150 mL of the gum arabic and gelatin solution prepared in S1 and 300 mL of the whey protein isolate solution were weighed and stirred for 10 min, then a 10% by weight lactic acid solution was slowly added to adjust the pH to 1.0, and the mixture was allowed to stand aseptically at room temperature of 20° C. for 2 h to allow phase separation, and then the solution was filtered to obtain the precipitate, i.e., the probiotic microcapsule wall material;

[0051] S3, preparation of compound probiotic dispersion: weigh 15g of commercially purchased Bifidobacterium breve BB-G95, 15g of Bifidobacterium animalis Bb-12, 15g of Bifidobacterium lactis Bi-07, 15g of Bifidobacterium bifidum, 15g of Lactobacillus casei, 8g of Lactobacillus plantarum, 8g of Lactobacillus reuteri, 8g of Lactobacillus delbrueckii subsp. lactis bulgaricus, 8g of Pediococcus acidilactici, 3g of Astragalus powder, 1.5g of dried tangerine peel powder, 1.5g of Codonopsis pilosula powder, and 20mL of polyglycerol polyricinoleate, place in 1.5L of corn oil, stir for 2h at 20°C to mix evenly, let stand for 12h to take out the precipitate for later use;

[0052] S4. Compound probiotic microcapsule molding: Weigh 150 g of the probiotic microcapsule wall material prepared in S2 and 150 g of the probiotic mixed precipitate prepared in S3, add them into a Wilmington homogenizer from the United States and stir at 5000 r / min for 90 s, then take out the microcapsules, dehydrate the solid materials by freeze-drying and package them, and thus obtain a compound probiotic preparation that can enhance human immunity and resist HPV infection.

[0053] Comparative Example 9: In step S1, except that food-grade gum arabic is not added, other parameters are the same as those of Example 3.

[0054] Comparative Example 10: In step S1, except that gelatin is not added, other parameters are the same as those in Example 3.

[0055] Evaluation of the survival rate of combined probiotics

[0056] This method uses a simulated in vitro model to construct a simulation experiment based on gastrointestinal enzyme conditions. The specific experimental model refers to the experimental method proposed in 10.1016 / j.foodassociation.2018.10.012. The encapsulated probiotic microcapsules are placed in the following environment to evaluate the survival rate of the probiotics.

[0057] In vitro simulated gastric fluid survival rate evaluation experiment phase 1: 10 g of microcapsules were dissolved in 100 mL of distilled water, and then 2 mol / L hydrochloric acid solution was added to adjust the pH to between 2.3 and 2.6, and 0.3 g of porcine gastric mucosal pepsin and 0.09 mg of camembert lipase purchased from Sigma-Aldrich, Sao Paulo, Brazil were added. The solution was transferred to a distillation flask and then oscillated at 2 r / min for 2 h in an oscillator incubator at 37 °C.

[0058] In vitro simulated intestinal fluid survival rate evaluation experiment phase 2: Take the above distillation flask and add 1 mol / L NaOH to raise the pH of the simulated gastric fluid system to 5.4-5.7, then add 1 g of porcine pancreatic enzyme purchased from Sigma-Aldrich, Sao Paulo, Brazil and 0.1 g of bovine bile, and continue to oscillate at 37°C for 2 h.

[0059] In vitro simulated intestinal fluid survival rate evaluation experiment stage 3: Take the distillation flask in stage 1 and add 1 mol / L NaOH to increase the pH of the simulated gastric fluid system to 6.8-7.2, then add 1 g of porcine pancreatic enzyme purchased from Sigma-Aldrich, Sao Paulo, Brazil and 0.1 g of bovine bile, and continue to oscillate at 37°C for 2 h.

[0060] After each stage, the number of surviving probiotics was determined. 1 mL of solution was extracted from each stage and diluted to 10 mL of 0.85% sodium chloride solution. The probiotic microorganisms were counted using the pour plate method. 1 mL of each microcapsule dilution of Examples 1-3 and Comparative Examples 1-10 was placed on an agar culture dish. The microstructure of the liquid was observed using an optical microscope with a magnification of 40×. A culture dish containing 20-200 colonies was selected and cultured in an anaerobic tank at 37°C for 3 days. The results were expressed as colony forming units (CFU) per milliliter of solution. The test results are shown in Table 2.

[0061] Table 2 Survival rate of compound probiotics in in vitro simulated fluid

[0062]

[0063] It can be seen from the data in Table 2 that after 6 hours of experiments with three stages of simulated gastric juice and intestinal juice, the survival rate of the probiotics in Examples 1-3 exposed to acidic solution can reach more than 88%, while the survival rate of the microcapsule probiotics after changing the ratio of gum arabic and gelatin and gum arabic and whey protein isolate has dropped significantly, reaching only about 60%. The survival rate of the microcapsule probiotics without adding gum arabic and gelatin is even worse, even less than 50%. This shows that microencapsulation can improve the survival rate of probiotics under severe acidic conditions of simulated gastric juice, and the microcapsules formed by the attractive interaction of gelatin and gum arabic in a specific ratio in acidic gastric juice will cause the effect of the two to be changed to repulsive effect in intestinal juice with a pH greater than 5, thereby causing the microcapsule structure to rupture and the release of probiotics and traditional Chinese medicine components, that is, targeted release in the human intestine.

[0064] Example 4

[0065] S1. Pretreatment of probiotic microcapsule wall material: Weigh 120 g of food-grade gum arabic and 120 g of gelatin powders, add them to 4 L of distilled water under sterile conditions, stir them at room temperature for 3 h to fully hydrate them, and then store them at 25 ° C for 12 h for standby use; weigh 240 g of whey protein isolate purchased from Hilma Co., Ltd., USA, and 2 L of sterile distilled water, stir them at room temperature for 30 min, then transfer the solution to a water bath at 80 ° C, heat and stir for 30 min, and then cool to 25 ° C for standby use;

[0066] S2, coagulation of probiotic microcapsule wall material: weigh 200 mL of the gum arabic and gelatin solution prepared in S1 and 400 mL of the whey protein isolate solution, stir them together for 10 min, then slowly add 10% by weight lactic acid solution to adjust the pH to 1.0, let stand aseptically at room temperature of 20° C. for 2 h to separate the phases, then filter the solution to obtain the precipitate, i.e., the probiotic microcapsule wall material;

[0067] S3. Preparation of compound probiotic dispersion: Weigh 20 g of commercially purchased Bifidobacterium breve BB-G95, 20 g of Bifidobacterium animalis Bb-12, 20 g of Bifidobacterium lactis Bi-07, 20 g of Bifidobacterium bifidum, 20 g of Lactobacillus casei, 10 g of Lactobacillus plantarum, 10 g of Lactobacillus reuteri, 0 g of Lactobacillus delbrueckii subsp. lactis, 10 g of Pediococcus acidilactici, 4 g of Astragalus powder, 2 g of Tangerine peel powder, 2 g of Codonopsis pilosula powder, and 30 mL of polyglycerol polyricinoleate, place in 2 L of corn oil, stir for 2 h at 20 ° C to mix evenly, let stand for 12 h to take out the precipitate for later use;

[0068] S4. Compound probiotic microcapsule molding: Weigh 200 g of the probiotic microcapsule wall material prepared in S2 and 200 g of the probiotic mixed precipitate prepared in S3, add them into a Wilmington homogenizer from the United States and stir at 5000 r / min for 90 s, then take out the microcapsules, dehydrate the solid materials by freeze-drying and package them, and thus obtain a compound probiotic preparation that can enhance human immunity and resist HPV infection.

[0069] Comparative Example 11: In step S3, except that astragalus and tangerine peel powder are not added, other parameters are the same as those in Example 4.

[0070] Comparative Example 12: In step S3, except that tangerine peel and codonopsis powder are not added, the other parameters are the same as those in Example 4.

[0071] Comparative Example 13: In step S3, except that Astragalus and Codonopsis powder are not added, other parameters are the same as those in Example 4.

[0072] Immunity enhancement test

[0073] In the "Evaluation Methods and Revisions for Immunity Enhancement Function", if any two of the four aspects of cellular immune function, humoral immune function, monocyte-macrophage function and NK cell activity are positive, it can be determined that the test sample has the effect of enhancing immunity. This manual uses humoral immune function and NK cell activity detection for experiments.

[0074] (1) Humoral immune function assay

[0075] This determination method refers to the evaluation criteria of the "Immunity Enhancement Function Evaluation Method and Revision Notes", including the determination of two items: antibody-producing cell detection and hemagglutination method for serum hemolysin. The specific experimental plan is as follows: 50 all-male BALB / c mice without specific pathogens were randomly divided into 5 groups of 10 mice each, all purchased from Beijing Weitong Lihua Experimental Animal Technology Co., Ltd., with a mass in the range of 20-25g, and a control group and an experimental group of Example 4 and Comparative Examples 11-13 were established respectively. Each mouse was given compound probiotic microcapsules at a feeding weight of 0.2g / kg body weight per day, and the control group was not given probiotic microcapsules, once a day, for 30 consecutive days. The determination methods of the relevant indicators of various functional determination tests were carried out in accordance with the "Catalogue of Health Functions Allowed to be Claimed by Health Foods: Non-Nutrient Supplements (2020 Edition) (Draft for Comments)", and the results were statistically analyzed. The results are shown in Tables 3 and 4.

[0076] Table 3 Effects of compound probiotics on mouse antibodies

[0077] Test samples <![CDATA[Hemolytic plaque number × 10 3 / Total spleen cells]]> Control group 171.62±9.60 Example 4 239.12±10.21 Comparative Example 11 172.30±8.66 Comparative Example 12 173.26±7.49 Comparative Example 13 176.98±11.25

[0078] Table 4 Effect of compound probiotics on serum hemolysin in mice

[0079] Test samples Antibody levels Control group 50.42±5.09 Example 4 70.59±5.23 Comparative Example 11 55.21±4.88 Comparative Example 12 53.67±3.62 Comparative Example 13 50.47±5.24

[0080] (2) NK cell activity assay

[0081] This determination method refers to the evaluation standard of "Immunity Enhancement Function Evaluation Method and Revision Instructions", including the determination of lactate dehydrogenase. The specific implementation method is the same as the humoral immune function determination method, and the specific experimental results are shown in Table 5.

[0082] Table 5 Effect of compound probiotics on NK cell activity in mice

[0083] Test samples <![CDATA[LDH activity / U·L -1 > Control group 270.31±10.32 Example 4 290.62±10.67 Comparative Example 11 275.66±8.54 Comparative Example 12 275.17±4.62 Comparative Example 13 276.37±7.35

[0084] It can be seen from the data in Table 3 that compared with the control group, the hemolytic plaque number index of the animals in Example 4 increased significantly, and the hemolytic plaque number index of the animals in Comparative Examples 11-13 increased slightly but not significantly compared with the control group. It can be analyzed from the data in Table 4 that compared with the control group, the serum antibody level of the animals in Example 4 increased significantly, while the serum antibody level of the animals in Comparative Examples 11-13 had almost no significant change. It can be seen from the data in Table 5 that compared with the control group not fed with the compound probiotic microcapsules, the NK cell activity of the animals in Example 4 increased significantly, while the animals in Comparative Examples 11-13 basically maintained the original level with only slight fluctuations. In summary, among the three results of the experimental determination of humoral immune function and NK cell activity, the number of hemolytic plaques, serum hemolysin antibody level and NK cell activity of mice fed with the microcapsules of the embodiment were significantly improved compared with those of the control group, and the measurement results were positive. In addition, the effect of adding the traditional Chinese medicine complex of astragalus, tangerine peel and codonopsis on the improvement of various indexes of mice was significantly better than the control group of selecting two from the three, indicating that the three have a significant synergistic effect on the improvement of immunity, thereby producing the effects of anti-inflammatory, bactericidal and resistance to HPV infection.

[0085] HPV infection resistance test

[0086] This determination method establishes a cervical cancer cell TC-1 tumor-bearing mouse model, uses the microcapsules prepared by the present invention to perform cell immunization on the mice, observes the tumor growth in the mice, and detects the in vitro lysis rate of mouse spleen cells on TC-1 cells, thereby testing the ability of the prepared drug to resist HPV infection. The specific experimental operation is as follows: First, HPV16-positive TC-1 cells purchased from the China Center for Type Culture Collection are routinely cultured to the logarithmic growth phase, and the cell concentration is controlled to 7*10 7 cells / mL for later use, then 1.5*10 6The cell units were injected into the back of SPF female BALB / c mice, all of which were purchased from Beijing Weitong Lihua Experimental Animal Technology Co., Ltd. 170 mice were randomly divided into 17 groups of 10 mice each, with a mass of 20-25g. The subcutaneous tumor formation of mice was observed once every 2 days and the tumor size was recorded for 30 consecutive days. A control group and an experimental group of Examples 1-4 and Comparative Examples 1-13 were established respectively, and each mouse was given a compound probiotic microcapsule at a feeding weight of 0.2g / kg body weight per day, and the control group was not given a probiotic microcapsule, once a day, for 30 consecutive days. After the feeding was completed, the mice were killed by cervical dislocation, and the mouse spleen cells were cultured in a T25 upright tissue culture flask using a CTL medium with an HPV polypeptide content of 1μg / mL, and the spleen cells were mixed with TC-1 target cells at a ratio of 100:1. The spleen cells were collected after 7 days, and the LDH release reaction was used to detect the killing effect of spleen cells on TC-1 target cells. The specific experimental results are shown in Table 6.

[0087] Table 6 Effect of compound probiotics on spleen cell lysis of TC-1 target cells

[0088]

[0089]

[0090] It is obvious from the data in Table 6 that compared with the control group not fed with the compound probiotic microcapsules, the TC-1 target cell lysis rate of mice fed with the example microcapsules increased significantly, while the TC-1 target cell lysis rate of mice fed with the comparative example microcapsules increased to a certain extent, but it was quite different from the example. This shows that feeding the example microcapsules greatly improves the ability of the spleen cells of mice to lyse TC-1 target cells infected with HPV virus, that is, the ability to resist HPV infection is significantly improved. And by comparing the target cell lysis rates of mice in Example 4 and Comparative Examples 11-13, it can be seen that the effect of adding the Chinese medicine composite of Astragalus, Tangerine Peel and Codonopsis on the target cell lysis rate of mice is significantly better than the effect of selecting two of the three, indicating that the three have a significant synergistic effect on improving the ability to resist HPV virus infection.

[0091] The above-mentioned embodiments only express the specific implementation methods of the present invention, and the descriptions thereof are relatively specific and detailed, but they cannot be understood as limiting the protection scope of the present invention. It should be pointed out that, for those skilled in the art, without departing from the concept of the present invention, any other changes, modifications, substitutions, combinations, simplifications made without departing from the spirit and principle of the present invention should be equivalent replacement methods and are included in the protection scope of the present invention.

Claims

1. A method for preparing a compound probiotic preparation for improving immunity and resisting HPV infection, characterized in that: S1. Pretreatment of probiotic microcapsule wall material: Weigh 30-120g of food-grade gum arabic and 30-120g of gelatin powder and add them to 1-4L of distilled water under sterile conditions, stir for 3h at room temperature to make it completely hydrated, and then store it at 25℃ for 12h for standby use; weigh 60-240g of whey protein isolate purchased from Hilma Co., Ltd., USA and 2L of sterile distilled water and stir for 30min at room temperature, then transfer the solution to a water bath at 80℃, heat and stir for 30min, and then cool Cool to 25°C for use; S2, coagulation of probiotic microcapsule wall material: weigh 50-2000.mL of gum arabic and gelatin solution prepared in S1, 100-400mL of whey protein isolate solution, stir together for 10min, then slowly add 10% lactic acid solution by mass to adjust the pH to 1.0, let stand aseptically at room temperature of 20°C for 2h to separate the phases, then filter the solution to take the precipitate, i.e., the probiotic microcapsule wall material; S3, preparation of compound probiotic dispersion: weigh commercially purchased Bifidobacterium breve BB -G95 10-20g, animal bifidobacterium Bb-12 10-20g, lactic acid bifidobacterium Bi-07 10-20g, bifidobacterium bifidum 10-20g, Lactobacillus casei 10-20g, Lactobacillus plantarum 5-10g, Lactobacillus reuteri 5-10g, Lactobacillus delbrueckii subsp. bulgaricus 5-10g, Pediococcus acidilactici 5-10g, Astragalus powder 2-4g, tangerine peel powder 1-2g, Codonopsis pilosula powder 1-2g, polyglycerol polyricinoleate 10-30mL, placed in 1-2L corn oil , stir for 2 hours at 20°C to mix evenly, let it stand for 12 hours and take the precipitate for use; S4, compound probiotic microcapsule molding: weigh 100-200g of the probiotic microcapsule wall material prepared in S2 and 100-200g of the probiotic mixed precipitate prepared in S3, add them into the American Wilmington homogenizer and stir at 5000r / min for 90s, then take out the microcapsule, dehydrate the solid material by freeze-drying and package it, and you can get the compound probiotic preparation that can improve human immunity and resist HPV infection.

2. The method for preparing a compound probiotic preparation for improving immunity and resisting HPV infection according to claim 1, characterized in that: The food-grade gum arabic, gelatin, and whey protein isolate weighed in S1 are 30 g, 30 g, and 60 g, respectively.

3. The method for preparing a compound probiotic preparation for improving immunity and resisting HPV infection according to claim 2, characterized in that: The S2 weighs 50 mL of the gum arabic and gelatin solution prepared in S1 and 100 mL of the whey protein isolate solution.

4. The method for preparing a compound probiotic preparation for improving immunity and resisting HPV infection according to claim 3, characterized in that: The S3 weighed Bifidobacterium breve BB-G95 is 10g, Bifidobacterium animalis Bb-12 is 10g, Bifidobacterium lactis Bi-07 is 10g, Bifidobacterium bifidum is 10g, Lactobacillus casei is 10g, Lactobacillus plantarum is 5g, Lactobacillus reuteri is 5g, Lactobacillus delbrueckii subsp. lactis bulgaricus is 5g, Pediococcus acidilactici is 5g, Astragalus powder is 2g, Tangerine peel powder is 1g, Codonopsis pilosula powder is 1g, polyglycerol polyricinoleate is 10mL, and corn oil is 1L.

5. The method for preparing a compound probiotic preparation for improving immunity and resisting HPV infection according to claim 4, characterized in that: The probiotic microcapsule wall material prepared by S2 and weighed by S4 are 100 g, and the probiotic mixed precipitate prepared by S3 are 100 g.

6. The method for preparing a compound probiotic preparation for improving immunity and resisting HPV infection according to claim 1, characterized in that: During the molding process of the S4 compound probiotic microcapsules, the stirring rate and time of the homogenizer were 5000 r / min and 90 s, respectively.

7. The compound probiotic preparation prepared according to any one of claims 1 to 6 for improving immunity and resisting HPV infection.